Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Services
Vetter Launches Vetter-Ject®
Thursday, July 16, 2015
Novel patented syringe system offers safety and convenience for patients.
XenoTech Adds In Vitro Toxicology to Its Drug Development Services
Wednesday, July 15, 2015
CRO XenoTech, LLC announces the addition of in vitro toxicology to its global drug development service portfolio.
Validive® at the MASCC/ISOO International Symposium
Wednesday, July 01, 2015
Oral presentation of Phase II trial results and meeting with its International Advisory Board.
Electromantles Engineered for Safety
Tuesday, June 30, 2015
Bibby Scientific’s Electromantles® from Electrothermal are engineered for safe and reliable heating of lab chemicals.
Merck Millipore Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service
Tuesday, June 16, 2015
Services accelerate time to the clinic by delivering high quality, high expressing cell lines.
Mylan Launches First Bioequivalent Alternative to Seretide® Evohaler®
Friday, June 12, 2015
Mylan becomes the first company to market a generic version of the UK's number one prescribed long-acting beta2-agonist + inhaled corticosteroid pressurized metered-dose inhaler asthma therapy.
Chemcap Clearview Cabinets are Easy to Assemble
Thursday, May 14, 2015
Bigneat knows that not everyone takes naturally to the idea of ‘do-it-yourself’. However, the easy-to-follow instructions and detailed diagrams in their new ‘Shortform User Manual’ show how easy it is to self-assemble your own ductless fume cabinet, whether you’re a flat-pack furniture novice or ‘build-your-own’ virtuoso.
Catalent Launches ADVASEPT™ Lock Delivery Technology
Friday, April 24, 2015
Company announces the expansion of its advanced, aseptic, glass-free injectable platform.
Rentschler Expands European Manufacturing Capabilities
Thursday, April 16, 2015
Companies celebrate handover of 1000th ÄKTAprocess.
Showing Results 1 - 10 of 309
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Advertise On This Site
Terms & Conditions
©2015 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,500+ scientific and medical posters
3,700+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FREE!